TCIM and breast cancer: Accumulated evidence have shown that TC-1 overexpression was detected in a wide range of solid tumors, including gastric cancer (Kim et al., 2006a), colon cancer (Friedman et al., 2004), breast cancer (Yang et al., 2007), and lung cancer (Su et al., 2013).